Literature DB >> 26259619

Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric Site.

Mohammad A Ghattas1, Ramez A Mansour1, Noor Atatreh1, Richard A Bryce2.   

Abstract

Enoyl-acyl carrier protein reductases have an important role in fatty acid biosynthesis and are considered essential for bacterial and protozoal survival. Here, we perform a computational assessment of enoyl-acyl carrier protein reductase structures, providing insights for inhibitor design that we incorporate into a virtual screening approach. Firstly, we analyse 80 crystal structures of 16 different enoyl-acyl carrier protein reductases for their active site characteristics and druggability, finding these sites contain a readily druggable pocket, of varying size and shape. Interestingly, a high affinity, potentially allosteric site was identified for pfFabl. Analysis of the ligand-protein interactions of four enoyl-acyl carrier protein reductases from different micro-organisms (InhA, pfFabl, saFabl and ecFabl), involving 59 available crystal structures, found three commonly shared interactions; constraining these interactions in docking improved enrichment of enoyl-acyl carrier protein reductase virtual screens, by up to 60% in the top 3% of the ranked library. This docking protocol also improved pose prediction, decreasing the root-mean-square deviation to crystallographic pose by up to 75% on average. The binding site analysis and knowledge-based docking protocol presented here can potentially assist in the structure-based design of new enoyl-acyl carrier protein reductase inhibitors.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  FabI; InhA; allosteric site; antibacterial agents; antimalarial; docking; druggability; enoyl-acyl carrier protein reductase; pharmacophore; protein-ligand interaction analysis; virtual screening

Mesh:

Substances:

Year:  2015        PMID: 26259619     DOI: 10.1111/cbdd.12635

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.

Authors:  Noor Atatreh; Mohammad A Ghattas; Sanaa K Bardaweel; Sara Al Rawashdeh; Mohammad Al Sorkhy
Journal:  Drug Des Devel Ther       Date:  2018-11-02       Impact factor: 4.162

2.  Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation.

Authors:  Ondrej Jandourek; Marek Tauchman; Pavla Paterova; Klara Konecna; Lucie Navratilova; Vladimir Kubicek; Ondrej Holas; Jan Zitko; Martin Dolezal
Journal:  Molecules       Date:  2017-02-02       Impact factor: 4.411

3.  Druggability analysis and classification of protein tyrosine phosphatase active sites.

Authors:  Mohammad A Ghattas; Noor Raslan; Asil Sadeq; Mohammad Al Sorkhy; Noor Atatreh
Journal:  Drug Des Devel Ther       Date:  2016-09-30       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.